TVTX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own TVTX shares is N/A, representing N/A of the company's common stock.

FMR LLC, in the last quarter, reduced its stake in TVTX by -1.35% restricting it's holding to 75.83 thousand shares of worth nearly $584.63K. LEGAL & GENERAL GROUP PLC also lessened -44.27% of the TVTX shares from its portfolio, reducing its holding to 75.15 thousand shares of worth $579.43M. PRUDENTIAL FINANCIAL INC also shunned TVTX shares holding by -26.72% last quarter which brought its holding to 65.26 thousand shares worth $503.16K.

As per its latest 13F filing, ARMISTICE CAPITAL, LLC increased its stake in TVTX by 1.57% in the last quarter. The institutional holder raised its holding to 7.5 million shares having worth more than $57.83M. CRESTLINE MANAGEMENT, LP also added 3.04% more shares of TVTX to its portfolio, raising its holding to 83.9 thousand shares of worth $646.86K. RICE HALL JAMES & ASSOCIATES, LLC also increased its TVTX shares holding by 4.47% which brought its holding to 73.4 thousand shares worth $565.91K.

The insider with the most stakes in TVTX is Dube Eric M , CHIEF EXECUTIVE OFFICER at the company. Additionally, TVTX stock is highly held by ASELAGE STEVE and CHIEF COMMERCIAL OFFICER Heerma Peter among others.

Company executives, directors, and other insiders own N/A percent of Travere Therapeutics, Inc.'s stock. Within the last six months, there have been 14 transaction(s) in which TVTX insiders have sold stock, totaling 126.39K shares. Insiders that have sold shares include INRIG JULA, CALVIN SANDRA, and LYONS GARY A.

There have been 0 transaction(s) during the past 6-months in which Travere Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 1.26M Travere Therapeutics, Inc. shares are held by insiders, which represents about N/A of TVTX stock.

TVTX CHIEF EXECUTIVE OFFICER, Dube Eric M holds the largest portfolio of the company's shares. TVTX shares owned by Dube total nearly 361.98 thousand.

ARMISTICE CAPITAL, LLC is the largest institutional owner in TVTX which holds 7.5 million shares worth $57.83M or 10.1% of the total TVTX shares outstanding followed by CRESTLINE MANAGEMENT, LP with ownership of 83.9 thousand shares representing 0.11% of the TVTX ownership. FMR LLC is the third largest stakeholder with 75.83 thousand shares or 0.1% of the ownership worth more than $584.63K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the TVTX is concerned, it is a stock which is optionable.

Number of TVTX shares short is 8.72M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 87.03M shares of TVTX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, TVTX has 57.87M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for TVTX is 7.07.